http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-1688-F2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
filingDate 1995-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c75338c30e43a673e2fe7c290ea38c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19002f9e8b8df35dac6e0ee9775acc78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08eb9d954182f71efa749e4a9c66676c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f42350c72c43d886e98c714600611fb
publicationDate 2001-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MD-1688-F2
titleOfInvention Benzothiophene, benzofuran and indoltiazepinone, oxazepinone and diazepinone, pharmaceutical composition, method of inhibiting leukocyte adhesion to endothelial cells for the treatment of inflammatory processes and the treatment method of mammals infected with HIV infection
abstract The invention refers to chemistry and medicine, namely, to the compounds of formula (I): <CHFORM>or to the acid additive salts used for treatment of inflammatory diseases and HIV infection.Summary of the invention consists in synthesis of the benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones of the formula (1), utilized as active ingredients in the pharmaceutical composition inhibiting leucocyte adherence to the endothelial cells, as well as the HIV activity. The claimed compounds may be used for inflammatory diseases and HIV infection treatment.Claims: 15
priorityDate 1994-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22648891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408470213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419761408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21962129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409300699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422085319

Total number of triples: 46.